Maternity

Reproductive Partners Medical Group, an Ivy Fertility Clinic, Expands With New Providers And New Location

Retrieved on: 
Wednesday, February 14, 2024
Women, Baby, Maternity, Genetics, Biotechnology, Family, Other Health, Managed Care, Health, Consumer, Infertility, Research, Suite, Reproductive medicine, MD, Dartmouth College, Physician, Growth, Molecular biology, Fertility, University, University of California, Davis, Immunology, Patient, University of California, California State University, Heart, Harvard Medical School, UCLA, RPMG, Medical device

Dr. Chang and Dr. Brower are both double board certified reproductive endocrinologists and infertility specialists.

Key Points: 
  • Dr. Chang and Dr. Brower are both double board certified reproductive endocrinologists and infertility specialists.
  • “Reproductive Partners Medical Group has stayed at the forefront of our field by honoring our heritage of excellence while continually looking toward the future,” said Lab Medical Director Gayane Ambartsumyan, MD.
  • She received her medical degree from University of California, Davis, and completed her residency in Obstetrics, Gynecology, and Reproductive Medicine at Harvard Medical School.
  • “This is an exciting time to join Reproductive Partners Medical Group and Ivy Fertility,” said Dr. Brower.

Munchkin Wins Favorable Decision in Patent Infringement Case Against TOMY International Inc.

Retrieved on: 
Wednesday, February 14, 2024
Professional Services, Retail, Consumer, Legal, Home Goods, Baby, Maternity, Caregiver, District court, Drinking, Patent, Mother, Child, Sippy cup, Soft drink

Munchkin, Inc. (“Munchkin” or “the Company) the beloved baby lifestyle brand owned by WHY Brands Inc. and the Company behind the most innovative gear and lifestyle products for children, mothers and caregivers, announced today a favorable decision by the U.S. District Court (Northern District of Illinois Eastern Decision) that found literal patent infringement by TOMY International Inc. (“TOMY”).

Key Points: 
  • Munchkin, Inc. (“Munchkin” or “the Company) the beloved baby lifestyle brand owned by WHY Brands Inc. and the Company behind the most innovative gear and lifestyle products for children, mothers and caregivers, announced today a favorable decision by the U.S. District Court (Northern District of Illinois Eastern Decision) that found literal patent infringement by TOMY International Inc. (“TOMY”).
  • “We are pleased with the ruling by the U.S. District Court, and its recognition of Munchkin’s decades-long investment in innovation,” said Steven B. Dunn, Founder and Chief Executive Officer of Munchkin.
  • “Munchkin has invested immense resources into its R&D efforts to create the most innovative gear and products for children, mothers and caregivers as demonstrated by Munchkin’s 340+ patents.
  • The court left open that TOMY’s Simply Spoutless Cups may also infringe additional claims under the asserted Munchkin utility patent as well as a second Miracle® 360° Sippy Cup patent, a design patent, as asserted by Munchkin.

Bright Horizons Family Solutions Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 13, 2024
Preschool, Human Resources, Parenting, Family, Baby, Maternity, Professional Services, Consumer, Education, Investment, Interest, Full service, Child care, Growth, Bright Horizons, Life, BFAM, GAAP, Tax, Depreciation, Video game

Bright Horizons Family Solutions® Inc. (NYSE: BFAM) today announced financial results for the fourth quarter and full year of 2023 and provided guidance for 2024.

Key Points: 
  • Bright Horizons Family Solutions® Inc. (NYSE: BFAM) today announced financial results for the fourth quarter and full year of 2023 and provided guidance for 2024.
  • Year Ended December 31, 2023 Highlights (compared to Year Ended December 31, 2022):
    “I am pleased to report solid financial results for the fourth quarter of 2023,” said Stephen Kramer, Chief Executive Officer.
  • Income from operations was $28.2 million for the fourth quarter of 2023 compared to $39.6 million for the fourth quarter of 2022, a decrease of 29%.
  • Diluted earnings per common share was $0.09 for the fourth quarter of 2023 compared to $0.31 for the fourth quarter of 2022.

Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference

Retrieved on: 
Tuesday, February 13, 2024
Women, Manufacturing, Seniors, Teens, Parenting, Men, Other Technology, Children, Baby, Maternity, Family, Medical Devices, Consumer, Consumer Electronics, LGBTQ+, Technology, General Health, Diabetes, Health, Other Manufacturing, Eastern Time Zone, Corporation, Webcast, Conference

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at The Raymond James & Associates 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5, 2024 at 11:35 a.m. (Eastern Time).

Key Points: 
  • Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at The Raymond James & Associates 45th Annual Institutional Investors Conference in Orlando on Tuesday, March 5, 2024 at 11:35 a.m. (Eastern Time).
  • To listen to the live audio webcast of the presentation, please visit investors.insulet.com/events .
  • A replay of the webcast will also be available following the event.

RH Unveils the Most Comprehensive Collection of New Outdoor Products in the Brand’s History

Retrieved on: 
Tuesday, February 13, 2024
Men, Luxury, Lifestyle, Specialty, Consumer, Catalog, Construction & Property, Teens, Retail, Baby, Maternity, Women, Interior Design, Home Goods, Collection, Light, LED, Multimedia, Aluminium, Gemini, Lighting, Taste, Worldwide Angel, Bauhaus, Book, Furniture

RH (NYSE: RH) announced today the release of the 2024 RH Outdoor Sourcebook .

Key Points: 
  • RH (NYSE: RH) announced today the release of the 2024 RH Outdoor Sourcebook .
  • “We are proud to introduce our latest Sourcebook, and the innovative global designers and artisan manufacturers we have partnered with.
  • The 2024 RH Outdoor collection boasts the world’s largest selection of TUUCI® architectural shade structures, crafted by Founder and Chief Architect Dougan Clarke, of Miami.
  • RH (NYSE: RH) is a curator of design, taste and style in the luxury lifestyle market.

ARC Fertility Celebrates Bill Glueck's One-Year Work Anniversary and Accomplishments as EVP of Partnerships & Platform Integrations

Retrieved on: 
Tuesday, February 13, 2024
Other Health, Professional Services, LGBTQ+, Family, Data Management, Consumer, Technology, Parenting, Baby, Maternity, Women, Insurance, Health, Multimedia, MD, Partnership, ARC, Fertility, Business development, API, SDOH, Medicare, Software as a service, Business, Fintech, Glück, Strategy

ARC Fertility (ARC) , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly marks the one-year anniversary of Bill Glueck's role as Executive Vice President of Partnerships & Platform Integrations.

Key Points: 
  • ARC Fertility (ARC) , a highly experienced national provider of innovative fertility and family-forming benefits for self-insured employers and their employees, proudly marks the one-year anniversary of Bill Glueck's role as Executive Vice President of Partnerships & Platform Integrations.
  • Glueck has played a pivotal role in advancing ARC’s mission of making affordable, flexible fertility and family-forming benefits more accessible for self-insured employers and their employees.
  • View the full release here: https://www.businesswire.com/news/home/20240213767636/en/
    Bill Glueck, Executive Vice President of Partnerships & Platform Integrations, ARC Fertility (Photo: Business Wire)
    “Glueck’s expertise and strategic vision have significantly contributed to ARC’s growth in the self-funded marketplace,” says Dr. David Adamson, MD, founder and CEO, ARC.
  • “Since joining ARC in April 2023, Glueck has spearheaded various initiatives to improve access to high-value, high-quality reproductive care for individuals of all backgrounds.

Which Test is Best? OB-GYN Lauren Streicher, M.D. Offers Expert Advice on Selecting Pregnancy Tests

Retrieved on: 
Tuesday, February 13, 2024
Other Consumer, Women, Seniors, Retail, Teens, Parenting, Baby, Maternity, Convenience Store, Family, Online Retail, Consumer, General Health, Other Retail, Health, Other Education, Supermarket, Specialty, Education, Urination, Feinberg School of Medicine, Urine, Birth, HCG, Gonadotropin, Digital, Pregnancy, Placenta, Confusion, Pregnancy test, Patient, Birth control

Lauren Streicher , M.D., OB-GYN, clinical professor at Northwestern University Feinberg School of Medicine, addresses the most common questions about purchasing pregnancy tests, providing expert insight on which test to choose.

Key Points: 
  • Lauren Streicher , M.D., OB-GYN, clinical professor at Northwestern University Feinberg School of Medicine, addresses the most common questions about purchasing pregnancy tests, providing expert insight on which test to choose.
  • “When speaking to patients, I find there is still a lot of confusion as to which at-home pregnancy test is right for them.
  • Whether actively trying to conceive or not, having access to accurate and reliable pregnancy tests can alleviate any uncertainties.”
    Dr. Streicher sheds light on the following considerations regarding purchasing at-home pregnancy tests:
    How do at-home pregnancy tests work?
  • Pregnancy tests detect human chorionic gonadotropin (hCG), the hormone produced by the placenta during pregnancy that is found in urine.

Children’s Hospital Los Angeles Unveils New Fetal Cardiac Clinic

Retrieved on: 
Tuesday, February 13, 2024
Nursing, Cardiology, Children, Baby, Maternity, Health, General Health, Family, Hospitals, Surgery, Consumer, Parenting, Master of Science, Division, CHLA, Multimedia, MSN, RN, Magnetic resonance imaging, CCRN, Ventricular septal defect, Pregnancy, Learning, Child, Risk, MHA, FRCPC, Circulant matrix, MHO, Patient, Senior counsel, Social, Heart, Diagnosis, Test management, MRI, Hospital

Children’s Hospital Los Angeles has opened its new Fetal Cardiac Clinic , a unique space for expectant mothers and the fetal patient population to continue receiving the highest level of comprehensive care during pregnancy, birth and beyond.

Key Points: 
  • Children’s Hospital Los Angeles has opened its new Fetal Cardiac Clinic , a unique space for expectant mothers and the fetal patient population to continue receiving the highest level of comprehensive care during pregnancy, birth and beyond.
  • View the full release here: https://www.businesswire.com/news/home/20240213588362/en/
    The Heart Institute at Children's Hospital Los Angeles celebrates the opening of its new Fetal Cardiac Clinic.
  • “With the launch of our new Fetal Cardiac Clinic, we now have a dedicated space that can serve as a one-stop shop for families in need of comprehensive prenatal diagnostic testing and counseling for cardiac anomalies.”
    CHLA’s state-of-the-art Fetal Cardiac Clinic features over 3,000 square feet of space and three scanning rooms dedicated to fetal cardiology.
  • Services provided at the CHLA Fetal Cardiac Clinic include:
    To learn more about CHLA’s Fetal Cardiac Clinic, visit CHLA.org/FetalCardiology or call 323-361-7398.

HRC Fertility Center Adds Dr. Irene Woo to Its Roster of Prominent Doctors

Retrieved on: 
Tuesday, February 13, 2024
Women, Hospitals, Baby, Maternity, Genetics, LGBTQ+, Practice Management, Health, Consumer, General Health, Gynaecology, Fertility preservation, MD, Reproductive technology, Fertility, IVF, HRC, Empathy, FACOG, Medicine, Patient, Journal, Patient safety, Environment, Diagnosis, Research, Book, Nursing

HRC Fertility Center (HRC), one of the largest providers of advanced fertility treatments based in Southern California, today announced the addition of Irene Woo, MD, FACOG , to its team of award-winning physicians.

Key Points: 
  • HRC Fertility Center (HRC), one of the largest providers of advanced fertility treatments based in Southern California, today announced the addition of Irene Woo, MD, FACOG , to its team of award-winning physicians.
  • Woo, an esteemed and compassionate medical professional holding dual board certifications in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility, has joined the center’s Encino office.
  • “I became part of HRC due to its esteemed reputation and commitment to exemplary medical practices,” said Dr.
  • Woo.

Pediatrix® Medical Group to Host National Neonatology Meetings Feb. 19-24

Retrieved on: 
Tuesday, February 13, 2024
Health, Consumer, Practice Management, Other Health, Baby, Maternity, Pharmaceutical, Biotechnology, Accreditation, Woman, FAAP, NEO, Research, Accreditation Council, MD, Physician, Health Promotion International, Quality, Pediatrics, Clinical research, Continuing medical education, Life, Conference, ACCME, Infant, Pediatrix Medical Group, Patient, Teaching, MPH, DRH, Child, Education, Nursing

Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada.

Key Points: 
  • Pediatrix Medical Group, Inc. (NYSE: MD), the nation’s leading provider of highly specialized health care for women, children and babies, will host the top meetings in neonatal-perinatal medicine Feb. 19-24 in Las Vegas, Nevada.
  • The meetings will host more than 600 combined attendees comprising neonatologists, neonatology fellows, pediatricians, advanced practice nurses and other allied health professionals, in addition to exhibitors and sponsors.
  • As a trusted provider of neonatology services for 45 years, Pediatrix cares for nearly a quarter of infants born in the U.S. that require intensive care.
  • , neonatologist and medical director at Pediatrix Neonatology of San Antonio, NEO continues its longstanding tradition of providing the latest information on key areas of neonatal management.